Changes in R-wave amplitude at implantation are associated with gender and orientation of insertable cardiac monitor: observations from the confirm Rx™ body posture and physical activity study

Matthew Swale, Vincent Paul, Sinny Delacroix, Glenn Young, Luke McSpadden, Kyungmoo Ryu, David Di Fiore, Maria Santos, Isabel Tan, Andre Conradie, MyNgan Duong, Nisha Schwarz, Stephen Worthley, Stephen Pavia, Matthew Swale, Vincent Paul, Sinny Delacroix, Glenn Young, Luke McSpadden, Kyungmoo Ryu, David Di Fiore, Maria Santos, Isabel Tan, Andre Conradie, MyNgan Duong, Nisha Schwarz, Stephen Worthley, Stephen Pavia

Abstract

Background: Insertable cardiac monitors (ICMs) are small subcutaneously implanted devices that detect changes in R-wave amplitudes (RWAs), effective in arrhythmia-monitoring. Although ICMs have proven to be immensely successful, electrical artefacts are frequent and can lead to misdiagnosis. Thus, there is a growing need to sustain and increase efficacy in detection rates by gaining insight into various patient-specific factors such as body postures and activities.

Methods: RWAs were measured in 15 separate postures, including supine, lying on the right-side (RS) or left-side (LS) and sitting, and two separate ICM orientations, immediately after implantation of Confirm Rx™ ICM in 99 patients.

Results: The patients (53 females and 46 males, mean ages 66.62 ± 14.7 and 66.40 ± 12.25 years, respectively) had attenuated RWAs in RS, LS and sitting by ~ 26.4%, ~ 27.8% and ~ 21.2% respectively, compared to supine. Gender-based analysis indicated RWAs in RS (0.32 mV (0.09-1.03 mV), p < 0.0001) and LS (0.37 mV (0.11-1.03 mV), p = 0.004) to be significantly attenuated compared to supine (0.52 mV (0.20-1.03 mV) for female participants. Similar attenuation was not evident for male participants. Further, parasternally oriented ICMs (n = 44), attenuated RWAs in RS (0.37 mV(0.09-1.03 mV), p = 0.05) and LS (0.34 mV (0.11-1.03 mV), p = 0.02) compared to supine (0.48 mV (0.09-1.03 mV). Similar differences were not observed in participants with ICMs in the 45°-relative-to-sternum (n = 46) orientation. When assessing the combined effect of gender and ICM orientation, female participants demonstrated plausible attenuation in RWAs for RS and LS postures compared to supine, an effect not observed in male participants.

Conclusion: This is the first known study depicting the effects on RWA due to body postures and activities immediately post-implantation with an overt impact by gender and orientation of ICM. Future work assessing the cause of gender-based differences in RWAs may be critical.

Trial registration: Clinical Trials, NCT03803969. Registered 15 January 2019 - Retrospectively registered, https://ichgcp.net/clinical-trials-registry/NCT03803969.

Keywords: Arrhythmia; Gender; Insertable cardiac monitor; Posture; R-wave amplitudes; Syncope.

Conflict of interest statement

SD, LM and KR are employees of Abbott. All other authors declare No Conflict of Interests for this article.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flowchart depicts Confirm Rx ™ Insertable Cardiac Monitor (ICM) study plan. Details on eligibility criteria provided in methods. ICM-Insertable Cardiac Monitor
Fig. 2
Fig. 2
R-wave amplitudes detected across all postural activities immediately following implant. Participant RWAs were assessed across 15 separate postures immediately following insertion of Confirm Rx™ ICM. On comparison to the Supine posture, lying on Right Side or Left side and Sitting were found to be significantly different in RWAs. Values for RWAs have been depicted as median and values range from minimum to maximum (n = 99). Significance was determined by Kruskal–Wallis test with p-value of < 0.05 considered significant. *** p-value of <0.001, *p-value of <0.05. Stand- Standing, Iso-Push- Isometric Push, Iso-Pull- Isometric Pull, Bal-Ballottement, CT- Chest Thumping, DP-Tip/Mid/Base- Device Pressure/Pressure on ICM at the tip, middle or lower part, AF- Arm Flaps, LHS- Left Arm Handshakes
Fig. 3
Fig. 3
R-wave amplitude showed significant association to lying on right side-and left side compared to supine posture in female participants. RWAs were plotted as Female (n = 53) vs Male (n = 46) participants. Values for R-waves have been depicted as median and values range from minimum to maximum. Significance was determined by Kruskal–Wallis test with p-value as <0.05 considered significant. **** P-value is <0.0001, *** p-value is <0.001. Stand- Standing, Iso-Push- Isometric Push, Iso-Pull- Isometric Pull, Bal-Ballottement, CT- Chest Thumping, DP-Tip/Mid/Base- Device Pressure/Pressure on ICM at the tip, middle or lower part, AF- Arm Flaps, LHS- Left Arm Handshakes
Fig. 4
Fig. 4
Position of ICM implant affected R-wave amplitude detected for female participants immediately following implant. RWAs for the two anatomical positions A. 45°relative to sternum (n = 46) and B. parallel to sternum (n = 44), selected for implanting Confirm Rx™ ICM. Parasternal positioning of ICM depicted differences in RS and LS postures compared to supine. Effect of gender was observed for RS and, RS and LS postures compared to Supine was observed for C. 45°relative to sternum (female n = 23 vs male n = 23) and D. parallel to sternum (female n = 26 vs male n = 18), respectively. Values for RWAs have been depicted as median and values range as minimum to maximum. Significance was determined by Kruskal–Wallis test or Mixed-effects Analysis with p-value as < 0.05 considered significant. *P-value is <0.05. RS = lying on Right Side, LS = lying on Left Side, Stand- Standing, Iso-Push- Isometric Push, Iso-Pull- Isometric Pull, Bal-Ballottement, CT- Chest Thumping, DP-Tip/Mid/Base- Device Pressure/Pressure on ICM at the tip, middle or lower part, AF- Arm Flaps, LHS- Left Arm Handshakes

References

    1. Bang OY, Ovbiagele B, Kim JS. Evaluation of cryptogenic stroke with advanced diagnostic techniques. Stroke. 2014;45(4):1186–1194. doi: 10.1161/STROKEAHA.113.003720.
    1. Goldberger ZD, Petek BJ, Brignole M, Shen WK, Sheldon RS, Solbiati M, Deharo JC, Moya A, Hamdan MH. ACC/AHA/HRS versus ESC guidelines for the diagnosis and management of syncope: JACC guideline comparison. J Am Coll Cardiol. 2019;74(19):2410–2423. doi: 10.1016/j.jacc.2019.09.012.
    1. Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med. 1996;100(6):646–655. doi: 10.1016/S0002-9343(95)00052-6.
    1. Subbiah R, Chia PL, Gula LJ, Klein GJ, Skanes AC, Yee R, Krahn AD. Cardiac monitoring in patients with syncope: making that elusive diagnosis. Curr Cardiol Rev. 2013;9(4):299–307. doi: 10.2174/1573403X10666140214120056.
    1. Krahn AD, Klein GJ, Yee R, Skanes AC. Detection of asymptomatic arrhythmias in unexplained syncope. Am Heart J. 2004;148(2):326–332. doi: 10.1016/j.ahj.2004.01.024.
    1. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. doi: 10.1056/NEJMoa1313600.
    1. Edvardsson N, Frykman V, van Mechelen R, Mitro P, Mohii-Oskarsson A, Pasquie JL, Ramanna H, Schwertfeger F, Ventura R, Voulgaraki D, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. 2011;13(2):262–269. doi: 10.1093/europace/euq418.
    1. Edvardsson N, Garutti C, Rieger G, Linker NJ, Investigators PS. Unexplained syncope: implications of age and gender on patient characteristics and evaluation, the diagnostic yield of an implantable loop recorder, and the subsequent treatment. Clin Cardiol. 2014;37(10):618–625. doi: 10.1002/clc.22300.
    1. Christensen LM, Krieger DW, Hojberg S, Pedersen OD, Karlsen FM, Jacobsen MD, Worck R, Nielsen H, Aegidius K, Jeppesen LL, et al. Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke final results from the surprise study. Eur J Neurol. 2014;21(6):884–889. doi: 10.1111/ene.12400.
    1. Krahn AD, Klein GJ, Norris C, Yee R. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995;92(7):1819–1824. doi: 10.1161/01.CIR.92.7.1819.
    1. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S, Mont L, Botto G, Giada F, Cornacchia D. International study on syncope of uncertain etiology I: Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104(11):1261–1267. doi: 10.1161/hc3601.095708.
    1. Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, Andresen D, Benditt DG, Vardas P. International study on syncope of uncertain etiology G: Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J. 2006;27(9):1085–1092. doi: 10.1093/eurheartj/ehi842.
    1. Kabra R, Gopinathannair R, Sandesara C, Messinger C, Olshansky B. The dual role of implantable loop recorder in patients with potentially arrhythmic symptoms: a retrospective single-center study. Pacing Clin Electrophysiol. 2009;32(7):908–912. doi: 10.1111/j.1540-8159.2009.02407.x.
    1. Podoleanu C, DaCosta A, Defaye P, Taieb J, Galley D, Bru P, Maury P, Mabo P, Boveda S, Cellarier G, et al. Early use of an implantable loop recorder in syncope evaluation: a randomized study in the context of the French healthcare system (FRESH study) Arch Cardiovasc Dis. 2014;107(10):546–552. doi: 10.1016/j.acvd.2014.05.009.
    1. Chrysostomakis SI, Klapsinos NC, Simantirakis EN, Marketou ME, Kambouraki DC, Vardas PE. Sensing issues related to the clinical use of implantable loop recorders. Europace. 2003;5(2):143–148. doi: 10.1053/eupc.2002.0301.
    1. Eitel C, Husser D, Hindricks G, Fruhauf M, Hilbert S, Arya A, Gaspar T, Wetzel U, Bollmann A, Piorkowski C. Performance of an implantable automatic atrial fibrillation detection device: impact of software adjustments and relevance of manual episode analysis. Europace. 2011;13(4):480–485. doi: 10.1093/europace/euq511.
    1. Miracapillo G, Addonisio L, Breschi M. F DES, manfredini E, Corbucci G, Severi S, Barold SS: Left axillary implantation of loop recorder versus the traditional left chest area: a prospective randomized study. Pacing Clin Electrophysiol. 2016;39(8):830–836. doi: 10.1111/pace.12875.
    1. Mittal S, Sanders P, Pokushalov E, Dekker L, Kereiakes D, Schloss EJ, Pouliot E, Franco N, Zhong Y, M DIB et al: Safety profile of a miniaturized insertable cardiac monitor: Results from two prospective trials. Pacing Clin Electrophysiol 2015 38(12): 1464–1469.
    1. Bellardine Black CL, Stromberg K, van Balen GP, Ghanem RN, Breedveld RW, Tieleman RG. Is surface ECG a useful surrogate for subcutaneous ECG? Pacing Clin Electrophysiol. 2010;33(2):135–145. doi: 10.1111/j.1540-8159.2009.02616.x.
    1. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104(1):46–51. doi: 10.1161/01.CIR.104.1.46.
    1. Sandesara CM, Gopinathannair R, Olshansky B. Implantable cardiac monitors: evolution through disruption. J Innov Card Rhythm Manag. 2017;8(9):2824–2834. doi: 10.19102/icrm.2017.080903.
    1. Ho C, Kurtzman SB. Three perspectives of cardiac electrical activity. Biomed Sci Instrum. 2001;37:325–330.
    1. Hedman K, Patti A, Moneghetti KJ, Hsu D, Christle JW, Ashley E, Hadley D, Haddad F, Froelicher V. Impact of the distance from the chest wall to the heart on surface ECG voltage in athletes. BMJ Open Sport Exerc Med. 2020;6(1):e000696. doi: 10.1136/bmjsem-2019-000696.
    1. Zellerhoff C, Himmrich E, Nebeling D, Przibille O, Nowak B, Liebrich A. How can we identify the best implantation site for an ECG event recorder? Pacing Clin Electrophysiol. 2000;23(10 Pt 1):1545–1549. doi: 10.1046/j.1460-9592.2000.01545.x.
    1. De Coster M, Demolder A, De Meyer V, Vandenbulcke F, Van Heuverswyn F, De Pooter J. Diagnostic accuracy of R-wave detection by insertable cardiac monitors. Pacing Clin Electrophysiol. 2020;43(5):511–517. doi: 10.1111/pace.13912.
    1. Tada S, Shibata M, Ohno S, Haruki Y, Murakami H, Hotta D, Nojima M, Ruhnke GW. Investigation on the optimal implantation site and setting of reveal LINQ((R)) avoiding interference with performance of transthoracic echocardiography. J Arrhythm. 2018;34(3):261–266. doi: 10.1002/joa3.12037.
    1. Reinsch N, Futing A, Howel D, Neven K. The Biomonitor III injectable cardiac monitor: clinical experience with a novel injectable cardiac monitor. J Clin Med. 2022;11(6):1643. doi: 10.3390/jcm11061634.
    1. Forleo GB, Amellone C, Sacchi R, Lombardi L, Lucciola MT, Scotti V, Viecca M, Schiavone M, Giacopelli D, Giammaria M. Factors affecting signal quality in implantable cardiac monitors with long sensing vector. J Arrhythm. 2021;37(4):1061–1068. doi: 10.1002/joa3.12585.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe